Skip to contentN
NEUROONE MEDICAL TECHNOLOGIES Corp
N
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp Q4 2014 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$166.00$166.00derived+18.6% vs Q4 2013 Net Income-$9.88K-$9.88KderivedN/M vs Q4 2013 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NEUROONE MEDICAL TECHNOLOGIES Corp · CIK 1500198 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$9,877N/M Margins · derivedOperating margin-5950.0%−4105.0 pt vs Q4 2013
Net margin-5950.0%−3812.1 pt vs Q4 2013
ended Dec 31, 2014 · filed Apr 15, 2015 · 105 d after period end